Enjoy complimentary customisation on priority with our Enterprise License!
The rapid microbiology testing market size is forecast to increase by USD 2.48 billion, at a CAGR of 9.31% between 2022 and 2027.
The growth of the market depends on several factors, including the increasing incidence of infectious diseases and cancer, the rise in the geriatric population, and the high prevalence of food-borne diseases. It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Rapid Microbiology Testing Market Research Report Sample PDF
The increasing incidence of infectious diseases and cancer is notably driving the market, although factors such as inadequate healthcare services in developing regions may impede the market. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing incidence of infectious diseases and cancer is the key factor driving the global market. The prevalence of infectious diseases such as tuberculosis, HIV, pneumonia, and malaria has increased. HIV attacks eventually destroy the immune system, resulting in AIDS, although this progression takes years. Thus, the body cannot defend itself against germs and infections as the immune system is compromised.
A compromised immune system makes the individual susceptible to diseases such as tuberculosis and pneumonia. There has been an increase in awareness programs related to infectious diseases such as HIV, cancer, tuberculosis, and pneumonia to encourage preventive healthcare or early diagnosis for improved treatment outcomes. With the global burden of these diseases increasing, the demand for rapid microbiology techniques for faster and more accurate microbial screening, identification, and testing against pathogens is expected to grow significantly during the forecast period.
The rise in food safety concerns is the primary trend in the global market. Individual food products are made up of plants and animals, and they usually contain a variety of microorganisms. Microbes from natural sources may come into contact with and contaminate food during manufacturing and consumption processes. Furthermore, microbial contamination of food items causes spoilage, which can result in foodborne illnesses if consumed. Foodborne illnesses are regarded as serious public health issues around the world.
The importance of food safety as a measure to prevent the spread of diseases is growing. In many countries, the government is significantly focusing on food-related safety standards. Regulatory authorities are constantly updating food safety regulations to ensure that the food and beverage industries deliver the optimum safety and quality of food products to consumers. Thus, the global market report is expected to grow during the forecast period.
The inadequate healthcare services in developing regions is a major challenge to the global market. Many people in developing regions such as APAC and MEA do not have the required knowledge or access to healthcare facilities to stay healthy. Also, the lack of financial resources is a major obstacle to public health, leading to an increase in infectious diseases, which is a significant public health concern. Moreover, healthcare systems in most developing countries are plagued by a lack of skilled personnel, making it difficult for them to provide access to quality healthcare services such as rapid microbiology testing.
The stigma or misconception about the gravity of conditions such as STDs further discourages any form of testing, including microbial testing and the subsequent treatment of infectious diseases. Hence, the drawbacks of developing countries, such as the prevalence of infectious diseases causing high mortality and morbidity, lack of skilled healthcare personnel and financial resources, and inadequate infrastructure and healthcare systems that are responsive to the needs of society, will hinder the market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
abbott.com - The company offers solutions for rapid microbiology testing that includes a wide range of BACT/ALERT 3D culture media bottles adapted to the type of microbial detection performed.
The market report also includes detailed analyses of the competitive landscape and information about 15 companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth of the growth-based segment will be significant during the forecast period. Growth-based rapid microbiological testing differs from traditional culture methods in that it relies on the detection of biochemical or physiological indicators rather. This generally allows for much faster detection, but it frequently necessitates a brief enrichment stage before microorganisms can be detected, especially in samples with low levels of contamination.
Get a glance at the market contribution of various segments Request Market Research Report Sample PDF
The growth-based segment was valued at USD 1.49 billion in 2017 and continued to grow until 2021. Growth-based microbiology testing can provide a quantitative cell count, an estimation of viable cell concentration, information about the presence of a specific microorganism, or microbial identification. The growth-based microbiology testing segment holds the largest market share in due to an increase in the early detection of infectious diseases, and it will continue to dominate the market during the forecast period.
For more insights on the market share of various regions Request Market Research Report Sample PDF
North America is projected to hold a 41% share of the market in 2023. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America was the largest revenue contributor to the global market in 2022, with the US being the leading country. The growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several companies in the country offering a wide range of microbial testing products are aiding the market. Therefore, the increase in emphasis on the production of drugs has played a major role in the adoption of microbial testing in the region.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by method, end-user, and region.
The market is driven by various factors, including the increasing incidence of infectious diseases and growing epidemics, leading to a rise in the demand for Diagnostic tests. This is also influenced by the Global burden of diseases, emphasizing the need for early disease detection. Emerging economies present significant growth opportunities, driven by factors such as increasing Disposable income and the expansion of Healthcare infrastructure. However, high capital investments and regulatory requirements serve as restraints, impacting the market's growth.
Technological advancements, such as Next-Generation Sequencing (NGS) and Real-time PCR, have revolutionized the market, offering advanced molecular diagnostic techniques. The collaboration of small emerging companies and the availability of low-cost clinical microbiology products are further propelling growth. Instruments such as Molecular cartridges and PCR coupled with mass spectrometry are driving the growth of the rapid microbiology testing segment. The market is also witnessing growth in Rapid diagnostic kits and Rapid POC diagnostic tests, catering to the clinical disease diagnosis segment. The market offers growth opportunities in emerging countries driven by the need for early disease detection. However, restraints such as high capital investments and low cost-benefit ratio challenge growth. Modernization in healthcare facilities and advancements in NGS (Next-Generation Sequencing) and pathogen-specific reagent/diagnostic kits drive innovation.
The global rapid microbiology testing market is witnessing significant growth, fueled by various factors outlined in recent research studies and industry trend analyses. One prominent driver is the increasing incidence of infectious diseases and the rise in outbreaks of epidemics worldwide. This necessitates swift and accurate detection methods to contain and manage these threats effectively.
Early disease detection remains a crucial aspect of healthcare, driving the demand for rapid microbiology testing solutions. This creates opportunities, particularly in emerging countries where disease prevalence is high, and there is a large patient population. Additionally, the growth of medical tourism further amplifies the need for rapid and reliable testing methods to ensure patient safety and efficient healthcare delivery. However, the market faces restraints such as high capital investments and a low cost-benefit ratio. Regulatory guidelines and the lengthy clinical trial phase also pose challenges to market growth.
Moreover, the availability and affordability of low-cost clinical microbiology products impact market dynamics, particularly in cost-sensitive regions.Within the market segments, the instruments segment plays a vital role in sample utilization and the growth of rapid microbiology testing solutions. R&D investments drive innovation and the development of advanced testing methodologies, contributing to the detection and management of various diseases. Additionally, government initiatives aimed at healthcare development further propel market expansion. Overall, the global rapid microbiology testing market is influenced by a complex interplay of factors, including disease prevalence, public immune system resilience, and new developments in the diagnostic market. As technology continues to advance and healthcare systems evolve, the market is poised for continued growth, albeit with challenges that necessitate strategic approaches and collaborative efforts from stakeholders across the industry.
Rapid Microbiology Testing Market Scope |
|
Report Coverage |
Details |
Page number |
156 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.31% |
Market growth 2023-2027 |
USD 2.48 billion |
Market structure |
Fragmented |
YoY growth (%) |
9.07 |
Regional analysis |
North America, Asia, Europe, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Biosensia Ltd., Bruker Corp., Charles River Laboratories, Colifast AS, Danaher Corp., Don Whitley Scientific Ltd., Euroclone SpA, Gradientech AB, Merck KGaA, Neogen Corp., Quidel Corp., Rapid Micro Biosystems Inc., rqMicro AG, Sartorius AG, Serosep Ltd., Solus Scientific Ltd., and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Request Market Research Report Sample PDF
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.